Spyglass Pharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Spyglass Pharma Inc's ROI in the second quarter of 2026?
Spyglass Pharma Inc had a negative return on investment (ROI) of -1360.85%, due to the net loss of $-2 billion, during the twelve months ending in the second quarter of 2026.

Within the Consumer Non Cyclical sector Spyglass Pharma Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	-99.36 %	-72.25 %	-46.38 %	-23.32 %	0.68 %
Y / Y Net Income Change TTM	-	-	-	0.86 %	339.51 %
Investment (TTM) in Millions	234	252	107	16	25,458
Return On Investment (TTM)	-1360.85 %	-29.96 %	-11.26 %	7.14 %	8.84 %
SGP's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-97.64 %	-48.26 %	-31.21 %	-23.99 %	2.56 %
Seq. Net Income Change TTM	-	-	-	-38.57 %	-14.62 %
Net Income (TTM) in Millions	-2,073	-1,935	-1,406	1,296	2,110

SGP Company Profile >> Back to SGP Roi Comparisons >> See Annual SGP Return On Investment

Return On Investment SGP's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Spyglass Pharma Inc's II. Quarter Investments	$ 234 Millions	SGP's Balance sheet
Spyglass Pharma Inc's II. Quarter Income	$ -20 Millions	Quarterly SGP's Income Statement
SGP's Income by Division		See SGP's Income by Division

SGP Annual Return On Investment	(Dec 31 2025) 2025	(FY 2008) (Dec. 30, 2008)	(FY 2007) (Dec. 30, 2007)	(FY 2006) (Dec. 30, 2006)	(FY 2005) (Dec. 30, 2005)
Total Investments in Millions	107	22,924	23,113	11,909	10,810
Y / Y Investment Growth	-99.53 %	-0.82 %	94.08 %	10.17 %	1 %
Net Income in Millions	-40	1,795	-1,473	1,121	269
Y / Y Net Income Growth	-	-	-	316.73 %	-
Annual Return On Investment	-37.16 %	7.83 %	-6.37 %	9.41 %	2.49 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Diversified Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
SGP's Roi Ratio versus Diversified Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGP's Competitors
Subscribers only: Roi for Spyglass Pharma Inc's Suppliers
Subscribers only: Return On Investment for SGP's Customers

Other Ratios
SGP's Roa	SGP's Inventory Turnover Ratio	SGP's Growth Rates	SGP's Dividend Statistics
	SGP's Profitability Ratios	SGP's Asset Turnover Ratio	SGP's Dividend Growth
SGP's Roe	SGP's Valuation Ratios	SGP's Financial Strength Ratios	SGP's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Consumer Non Cyclical Sector

ROI

Date modified: 2026-09-26T07:43:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.